Navigation Links
NIOXIN(R) Delivers the Future to Scalp and Hair Care, Introduces the First Genetic Test to Determine the Likelihood of Hair Loss

Leading Scalp and Hair Care Company Enters Agreement with HairDX to Offer

Consumer-Friendly Hair Loss Test

ATLANTA, March 6 /PRNewswire/ -- NIOXIN(R) Research Laboratories Inc., the leader in professional skincare for the scalp, today announced that it will offer an easy to access and understand genetic test that determines the likelihood of developing male pattern baldness -- before it actually begins to happen. Similarly, a test for women is being developed and may be available soon.

NIOXIN(R) has entered into an agreement with HairDX, a biotech start-up based in Irvine, CA, to offer the test as part of its next generation effort in introducing scientifically proven scalp and hair products. HairDX is the first genome test to be made available to consumers in helping assess their risk and genetic predisposition for developing pattern baldness (Androgenetic Alopecia). This new genetic test is accessible through the internet at and will be promoted at consumer education events held nationally beginning March 1st 2008.

According to the American Hair Loss Association, by the age of 35, two-thirds of American men will experience some degree of appreciable hair loss and by the age of 50, approximately 85% of men will have significantly thinning hair.

"Gaining a better understanding of the potential cause of an individual's condition enables a more accurate assessment of the most appropriate solution," said Eva Graham, founder of NIOXIN(R) Research Laboratories, Inc.

"HairDX is proud to work with NIOXIN(R) to help genetic science make a positive contribution to scalp and hair care," said Andy Goren, CEO of HairDX. "This provides a personalized profile for many individuals who can benefit from knowing their risk of hair loss and allow them to take action early, before the condition becomes severe."


The participant simply swabs their mouth (inside cheek) for several seconds and returns the swab in a sealed pack to the HairDX lab. HairDX performs a confidential and anonymous genetic analysis of the individual's genetic variations related to pattern baldness. The confidential results are delivered via a secure Web site.

"HairDX tests for a genetic variant found in more than 95% of bald men. 60% of patients with this variant experienced male pattern baldness before the age of 40, thus it is a marker for a significant increased risk of pattern baldness," says Professor Doron Lancet, PhD, a pioneer of genome research and Head of the Crown Human Genome Center at the Department of Molecular Genetics, Weizmann Institute of Science in Rehovot, Israel. "This is in contrast to the less common genetic variant of the same gene, present in about 1 in 6 people, which indicates greater than 85% likelihood that a person will not experience early onset pattern baldness."

About HairDX

Based in Irvine, CA, HairDX was founded by leading researchers and specialists in genetic analysis and hair therapies. The company is dedicated to helping people make the right decisions about hair care, treatment and restoration by providing accurate and accessible personalized scientific information.

Among HairDX founders is William V. Murray former Division President of the Molecular Biology Division of Applied BioSystems, Inc., who formerly served in various executive leadership positions within Medtronic; Andy Goren former CEO of MobileWise, Inc. and GeePS, Inc.; Eran Goren, CEO of enCircle Media, Inc.; Professor Doron Lancet, PhD, Head of the Crown Human Genome Center at the Department of Molecular Genetics, Weizmann Institute of Science; Dr. Peter Novak, a Neurologist at the University of Massachusetts Medical Center; Elliott J. Stein, an intellectual property attorney and co-founder of GeePS, Inc. and Mace Wolf. HairDX, LLC is a subsidiary of myGenopedia, Inc. More information is available at

About NIOXIN Research Laboratories Inc.

NIOXIN(R) is the leading provider of advanced skincare solutions that treat the scalp to improve the appearance of fine and thinning hair. Founded in 1987 by Eva Graham, this privately-held company has been dedicated to providing education and products for consumers through the professional salon industry around the world. Distributed in more than 42 countries on six continents, NIOXIN(R) continues to define the meaning of innovation and leadership for the global market of fine and thinning hair. Additional information is available at or at 800-789-9617.

Contact: Rebecca Levy for NIOXIN PR


SOURCE NIOXIN Research Laboratories Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. CompareNetworks Media Group Delivers CME/CE Through Acuity Medical Education
2. Nikon Instruments New NIS-Elements C Delivers Comprehensive Confocal and Widefield Imaging Capabilities in Single Unifying Software Platform
3. Millennium Over-Delivers on 2007 Goals and Financial Guidance
4. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
5. Advancements in Population Age and Technology Drive Future of Orthopedic Materials Market
6. Coherent Sets Future Financial Target
7. Nanotube forests grown on silicon chips for future computers, electronics
8. Growing tiny carbon nanotube wires to connect computer chips of the future
9. Solar cells of the future
10. NASA technology helps predict and prevent future pandemic outbreaks
11. Carrington Settles Lawsuit, Sets Sights On Future
Post Your Comments:
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is one ... biomarkers market with pharmaceutical companies and diagnostic ... diagnostic tests. . ... Complete report on global cancer biomarkers market ...
(Date:11/25/2015)... 26, 2015 --> ... 2016 - 2020 report analyzes that automating biobanking ... quality in long-term samples, minimizing manual errors, improving ... minimizes manual errors such as mislabeling or inaccurate ... it plays a vital role in blood fractionation, ...
(Date:11/25/2015)... , November 25, 2015 ... cat and human plaque and pave the way for more ... problems in cats     --> ... most commonly diagnosed health problems in cats, yet relatively little ... now. Two collaborative studies have been conducted by researchers from ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
Breaking Biology Technology:
(Date:10/26/2015)... Calif. and LAS VEGAS ... Nok Nok Labs , an innovator in modern authentication ... , today announced the launch of its latest version ... unified platform enabling organizations to use standards-based authentication that ... Nok Nok S3 Authentication Suite is ideal for organizations ...
(Date:10/23/2015)... 23, 2015 Research and Markets ( ... Voice Recognition Biometrics Market 2015-2019" report to their ... The global voice recognition biometrics market to grow ... --> --> The report, ... based on an in-depth market analysis with inputs from ...
(Date:10/22/2015)... Mass., Oct. 22, 2015  Aware, Inc. (NASDAQ: AWRE ), ... results for its third quarter ended September 30, 2015.  ... quarter of 2015 was $4.0 million, a decrease of 33% compared ... in the third quarter of 2015 was $2.2 million, or $0.10 ... diluted share, in the same period a year ago.  ...
Breaking Biology News(10 mins):